Home > Insider Trading > Filing (0001415889-24-020945)

Filing Details

Accession Number:: 0001415889-24-020945
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-08-07 18:56:51
Reporting Period:: 2024-08-05

Accepted Time:: 2024-08-07 18:56:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1484565	Soleno Therapeutics Inc	SLNO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1422484	H James Mackaness	203 Redwood Shores Pkwy, Ste 500 Redwood City CA 94065	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2024-08-05	3,858	$45.48	151,905	No	4	S	Direct
Common Stock	Disposition	2024-08-05	2,991	$46.14	148,914	No	4	S	Direct
Common Stock	Disposition	2024-08-06	799	$43.64	148,115	No	4	S	Direct
Common Stock	Disposition	2024-08-06	2,699	$45.25	145,416	No	4	S	Direct
Common Stock	Disposition	2024-08-06	4,636	$45.89	140,780	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
This transaction was executed in multiple trades at prices ranging from $44.87 to $45.86. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
This transaction was executed in multiple trades at prices ranging from $45.87 to $46.64. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $43.245 to $44.17. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $44.66 to $45.655. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $45.66 to $46.40. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.